665 related articles for article (PubMed ID: 19001139)
1. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.
Jones RB; Ndhlovu LC; Barbour JD; Sheth PM; Jha AR; Long BR; Wong JC; Satkunarajah M; Schweneker M; Chapman JM; Gyenes G; Vali B; Hyrcza MD; Yue FY; Kovacs C; Sassi A; Loutfy M; Halpenny R; Persad D; Spotts G; Hecht FM; Chun TW; McCune JM; Kaul R; Rini JM; Nixon DF; Ostrowski MA
J Exp Med; 2008 Nov; 205(12):2763-79. PubMed ID: 19001139
[TBL] [Abstract][Full Text] [Related]
2. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
[TBL] [Abstract][Full Text] [Related]
3. Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection.
Sakhdari A; Mujib S; Vali B; Yue FY; MacParland S; Clayton K; Jones RB; Liu J; Lee EY; Benko E; Kovacs C; Gommerman J; Kaul R; Ostrowski MA
PLoS One; 2012; 7(7):e40146. PubMed ID: 22792231
[TBL] [Abstract][Full Text] [Related]
4. Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway.
Mujib S; Jones RB; Lo C; Aidarus N; Clayton K; Sakhdari A; Benko E; Kovacs C; Ostrowski MA
J Immunol; 2012 Apr; 188(8):3745-56. PubMed ID: 22422881
[TBL] [Abstract][Full Text] [Related]
5. HIV infection deregulates Tim-3 expression on innate cells: combination antiretroviral therapy results in partial restoration.
Finney CA; Ayi K; Wasmuth JD; Sheth PM; Kaul R; Loutfy M; Kain KC; Serghides L
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):161-7. PubMed ID: 23314411
[TBL] [Abstract][Full Text] [Related]
6. Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.
Hoffmann M; Pantazis N; Martin GE; Hickling S; Hurst J; Meyerowitz J; Willberg CB; Robinson N; Brown H; Fisher M; Kinloch S; Babiker A; Weber J; Nwokolo N; Fox J; Fidler S; Phillips R; Frater J;
PLoS Pathog; 2016 Jul; 12(7):e1005661. PubMed ID: 27415828
[TBL] [Abstract][Full Text] [Related]
7. Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients.
Sada-Ovalle I; Ocaña-Guzman R; Pérez-Patrigeón S; Chávez-Galán L; Sierra-Madero J; Torre-Bouscoulet L; Addo MM
J Int AIDS Soc; 2015; 18(1):20078. PubMed ID: 26486200
[TBL] [Abstract][Full Text] [Related]
8. Revisiting immune exhaustion during HIV infection.
Khaitan A; Unutmaz D
Curr HIV/AIDS Rep; 2011 Mar; 8(1):4-11. PubMed ID: 21188556
[TBL] [Abstract][Full Text] [Related]
9. Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children.
Tandon R; Giret MT; Sengupta D; York VA; Wiznia AA; Rosenberg MG; Kallas EG; Ndhlovu LC; Nixon DF
PLoS One; 2012; 7(9):e45733. PubMed ID: 23029209
[TBL] [Abstract][Full Text] [Related]
10. TIMs: central regulators of immune responses.
Hafler DA; Kuchroo V
J Exp Med; 2008 Nov; 205(12):2699-701. PubMed ID: 19015312
[TBL] [Abstract][Full Text] [Related]
11. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques.
Fujita T; Burwitz BJ; Chew GM; Reed JS; Pathak R; Seger E; Clayton KL; Rini JM; Ostrowski MA; Ishii N; Kuroda MJ; Hansen SG; Sacha JB; Ndhlovu LC
J Immunol; 2014 Dec; 193(11):5576-83. PubMed ID: 25348621
[TBL] [Abstract][Full Text] [Related]
12. Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.
Crawford TQ; Hecht FM; Pilcher CD; Ndhlovu LC; Barbour JD
PLoS One; 2013; 8(10):e77412. PubMed ID: 24143233
[TBL] [Abstract][Full Text] [Related]
13. Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.
Clayton KL; Douglas-Vail MB; Nur-ur Rahman AK; Medcalf KE; Xie IY; Chew GM; Tandon R; Lanteri MC; Norris PJ; Deeks SG; Ndhlovu LC; Ostrowski MA
J Virol; 2015 Apr; 89(7):3723-36. PubMed ID: 25609823
[TBL] [Abstract][Full Text] [Related]
14. TIM-3 does not act as a receptor for galectin-9.
Leitner J; Rieger A; Pickl WF; Zlabinger G; Grabmeier-Pfistershammer K; Steinberger P
PLoS Pathog; 2013 Mar; 9(3):e1003253. PubMed ID: 23555261
[TBL] [Abstract][Full Text] [Related]
15. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE
J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065
[TBL] [Abstract][Full Text] [Related]
16. Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy.
de Armas LR; Pallikkuth S; Rinaldi S; Pahwa R; Pahwa S
AIDS Res Hum Retroviruses; 2019; 35(11-12):1112-1122. PubMed ID: 31578868
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells.
Che KF; Sabado RL; Shankar EM; Tjomsland V; Messmer D; Bhardwaj N; Lifson JD; Larsson M
Eur J Immunol; 2010 Aug; 40(8):2248-58. PubMed ID: 20455275
[TBL] [Abstract][Full Text] [Related]
18. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
[TBL] [Abstract][Full Text] [Related]
19. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
[TBL] [Abstract][Full Text] [Related]
20. Short-circuiting regulatory T-cell proliferation during chronic infection.
Liston A; Kim JM
Immunol Cell Biol; 2009; 87(6):443-4. PubMed ID: 19399027
[No Abstract] [Full Text] [Related]
[Next] [New Search]
